Vote for Amarantus as your 'favorite innovative biotech company' in the 'Pipelines of Promise and Technologies of Tomorrow' category! Voting ends April 22nd, winners to be announced April 24th. http://bit.ly/1p7qcaY

Apple is now highlighting how its tablet can be used for more than just entertainment and content consumption. The company is now advertising "C3 Logix," an app designed to measure the health of athletes after a concussion. http://on.mash.to/Offn5F

Amarantus appoints Dr. Charlotte Keywood as Chief Medical Officer of it's therapeutics division. Dr. Keywood brings over 20 years of experience in the biopharmaceutical drug development industry. CEO Gerald Commissiong states "We believe this experience will be of great value to Amarantus as we prepare to continue the development of Eltoprazine into Phase 2b clinical trials." http://bit.ly/PYImvv

"I used to be the athlete," said Allison Kasacavage. "Now I'm the girl with concussions." Kasacavage, 17, suffers daily with the aftereffects of concussions from soccer. Christina L. Master, a sports-medicine specialist and concussion researcher at the Children's Hospital of Philadelphia always believed young athletes recovered quickly from a concussion; she is now seeing this is not the case; and something needs to be done. http://bit.ly/1j4Nato

Amarantus appoints Robert Farrell J.D. as Chief Financial Officer; bringing over 20 years of healthcare, public company and CFO experience to the Company. "We expect 2014 to be a transformative year for Amarantus as we lay the groundwork for long-term shareholder value creation," states Mr. Farrell. http://bit.ly/1olB58Q

Amarantus reported financial results and development progress for the year ended December 31, 2013. The Company will host a conference call on Thursday, April 24th at 4:05pm ET to provide updates and address investor questions. CEO Gerald Commissiong states, "2013 was an important year for Amarantus as we improved our balance sheet substantially, and laid the groundwork for significant growth in 2014." http://bit.ly/1r8uzA0

Twelve year old Devin Kerby is living daily with the effects of TBI from a major car crash she suffered at just 4 years old. Today, she does all she can to raise money for this "silent epidemic." http://bit.ly/OfeTfI

More than 5.4 million Americans are living with Alzheimer’s disease, and a new report by the Alzheimer’s Association shows women are hit especially hard. Women after the age of 60 are more likely to develop Alzheimer's than breast cancer, they are also at the "at the epicenter of caregiving for someone with Alzheimer’s.” Angela Geiger, Chief Strategy Officer of the Alzheimer’s Association hopes this report will help move Alzheimer's treatment to center stage. http://onforb.es/1j4OQ6n

Follow our LinkedIn page and join today’s conversation on the LymPro Test. https://www.linkedin.com/company/amarantus-biosciences

In his new blog post CEO Gerald Commissiong details the Company's recent achievement of key milestones that Amarantus believes will add significant value to the commercialization of the LymPro Test. He also introduced the newest member of the Amarantus team, Paul Jorgenson as Head of Product Development. Read full blog here: http://bit.ly/1oiamd3